🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

10 recruiting trials

for Recurrent Pancreatic Ductal Adenocarcinoma

Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapy NCT04881487NA3 sites📍 Amsterdam📍 Rotterdam📍 Utrecht UMC Utrecht · Tests: Additional stereotactic body radiation therapy A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer NCT07227168Phase 19 sites📍 San Diego📍 Denver📍 Washington D.C. Sutro Biopharma, Inc. · Tests: STRO-004, Pembrolizumab The HELPP Score: A Pretreatment Score to Predict Survival in Pancreatic Cancer NCT05752812n/a1 site📍 Vienna Medical University of Vienna To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors NCT07594964Phase 12 sites📍 Beijing📍 Beijing Shenzhen Xinhe Biomedical · Tests: XH001 Injection, mFOLFIRINOX Treatment Regimen Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC) NCT07733674Phase 11 site📍 Houston Radiomedix, Inc. · Tests: 203Pb-RMX-VHPIB injection, SPECT/CT Imaging A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites📍 Los Angeles📍 Los Angeles📍 Whittier Daiichi Sankyo · Tests: Ifinatamab deruxtecan Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors NCT04851119Phase 1, Phase 221 sites📍 Birmingham📍 Los Angeles📍 Orange Children's Oncology Group · Tests: Biospecimen Collection, Dual X-ray Absorptiometry, Tegavivint, X-Ray Imaging Autologous CAR-T Cells Targeting B7-H3 in PDAC NCT06158139Phase 11 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: iC9-CAR.B7-H3 T cell infusion Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors NCT07410494Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EB-SELECT Single-Target CAR-NK Cells, Dual-Target Antigen-Selected CAR-NK SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells NCT04150042Phase 12 sites📍 Boston📍 New York General Oncology, Inc. · Tests: Melphalan, BCNU, Vitamin B12B, Vitamin C, Autologous Hematopoietic Stem Cells
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy